InVivo Therapeutics Corporation's Interim CFO Quits After 2 Weeks

Published: Sep 11, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Interim CFO Sean Moran quits InVivo Therapeutics after just 2 weeks on the job, sending share prices down nearly 22% today. InVivo Therapeutics (OTC:NVIV) shares plunged some 22% today after the medical device company reported that its interim CFO, appointed 2 weeks ago after the sudden departure of CEO & CFO Frank Reynolds, had resigned effective immediately. NVIV shares were trading at $1.61 each as of about 3:20 p.m. today, down 21.5%. Cambridge, Mass.-based InVivo's shares plunged some 28% August 27, days after Reynolds' departure, when it said the timeline for clinical trials of its spinal cord injury treatment would be delayed for years.

Help employers find you! Check out all the jobs and post your resume.

Back to news